Macy's Inc (MACY34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 19 Oct 2026
Key indicators
| Last close | BRL 119.68 |
|---|---|
| 52-week range | 87.90 – 136.75 |
| Return, 1 month / 3 months | +1.9% / +1.7% |
| Return, 1 year / 3 years | +24.1% / +126.9% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 44.2% |
| Worst drawdown (1 year) | -34.1% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Macy's Inc is an American department store company based in New York City. It runs department stores under the Macy's and Bloomingdale's names, along with the Bluemercury beauty chain, offering clothing, accessories, cosmetics, home furnishings and other goods. Its customers are everyday shoppers and gift buyers, served through stores across the United States and through its online shopping channels, where the company also fulfils orders placed by customers.
Macy's Inc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code MACY34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Macy's Inc (MACY34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 119.68 on 19 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 692 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 24.1% and over the last three months it rose 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.4% | ||
| From 52-week high | -11.8% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.7% | ||
| 6-month return | 22.4% | ||
| 12-month return, skipping the last month | 21.7% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.1% | ||
| Liquidity | 17 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 48.3% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.6% |
|---|---|
| 1 month | +1.9% |
| 3 months | +1.7% |
| 6 months | +22.4% |
| 1 year | +24.1% |
| 3 years | +126.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 118.10 / 111.43 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.07 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | USD 0.6728 |
| 11 Mar 2026 | USD 0.6690 |
| 11 Dec 2025 | USD 0.6705 |
| 11 Sep 2025 | USD 0.6594 |
| 11 Jun 2025 | USD 0.6725 |
| 12 Mar 2025 | USD 0.7022 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.